Beneficiary 8: TAG

Tagworks Pharmaceuticals BV (TAG)

Scientist in Charge: Marc Robillard

Tagworks Pharmaceuticals BV, a Philips Research spin out, is developing a unique approach towards antibody-based imaging and therapy. Tagworks’ technology enables the actuation of tagged antibodies through selective bio-orthogonal chemical manipulation in vivo, improving the efficacy of established approaches such as Radioimmuno-imaging and –therapy and Antibody-Drug Conjugates.